series-b
Stage
About
Dthera Sciences is a clinical-stage biopharmaceutical company focused on developing novel treatments for central nervous system disorders including Fragile X syndrome and neurodevelopmental disorders.
Explore Dthera Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.